Change page: Consider β blockers for patients with heart failure

BMJ (Online)

Volumn 338, Issue 7707, 2009, Pages 1384-1385

  Krum, Henry ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

EVIDENCE BASED PRACTICE; HEALTH SURVEY; HEART FAILURE; HUMAN; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY; ARTICLE; CHRONIC DISEASE; PROFESSIONAL PRACTICE;

ADRENERGIC BETA-ANTAGONISTS; CHRONIC DISEASE; HEART FAILURE; HUMANS; PROFESSIONAL PRACTICE;

EID: 67650078975     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b1728     Document Type: Short Survey

References (15)

1. Krum H, Jelinek MV, Stewart S, Sindone A, Atherton JJ, Hawkes AL, CHF Guidelines Core Writers. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006. Med J Aust 2006;185:549-57.[Web of Science][Medline]
2. Sackner-Bernstein JD, Mancini DM. Rationale for treatment of patients with chronic heart failure with adrenergic blockade. JAMA 1995;274:1462-7.[Abstract/Free Full Text]
3. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, et al, Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003;24:464-74.[Abstract/Free Full Text]
4. Franciosa JA, Massie BM, Lukas MA, Nelson JJ, Lottes S, Abraham WT, et al, COHERE Participant Physicians. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry Am Heart J 2004;148:718-26.[CrossRef][Web of Science][Medline]
5. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al, US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.[Abstract/Free Full Text]
6. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet 1999;353:9-13.[CrossRef][Web of Science][Medline]
7. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7. [CrossRef][Web of Science][Medline]
8. Packer M, Coats A, Fowler M, Roecker EB, Coats AJS, Katus HA, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8.[Abstract/Free Full Text]
9. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, et al, SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005;26:215-25. [Abstract/Free Full Text]
10. Colucci WS, Kolias TJ, Adams KF, Armstrong WF, Ghali JK, Gottlieb SS, et al, REVERT Study Group. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial. Circulation 2007;116:49-56. [Abstract/Free Full Text]
11. McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, et al, CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 2003;362:767-71.[CrossRef][Web of Science][Medline]
12. Krum H, Ninio D, MacDonald P. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure. Heart 2000;84:615-9.[Abstract/Free Full Text]
13. Krum H, Hill J, Fruhwald F, Sharpe C, Abraham G, Zhu JR, et al. Tolerance of beta-blockers in elderly patients with chronic heart failure: the COLA II study. Eur J Heart Fail 2006;8:302-7. [Abstract/Free Full Text]
14. Maggioni AP, Sinagra G, Opasich C, Geraci E, Gorini M, Gronda E, et al, on behalf of BRING-UP Investigators. Treatment of chronic heart failure with β adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. Heart 2003;89:299-305.[Abstract/Free Full Text]
15. Lenzen MJ, Boersma E, Reimer WJ, Balk AH, Komajda M, Swedberg K, et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J 2005;26:2706-13.[Abstract/Free Full Text]